Canine cardiology study to be published this fall
St. Joseph, Mo. -- A three-year global canine cardiology study funded by Boehringer Ingelheim Animal Health that could reveal new information about congestive heart failure treatments has concluded.
St. Joseph, Mo.
-- A three-year global canine cardiology study funded by Boehringer Ingelheim Animal Health that could reveal new information about congestive heart failure treatments has concluded.
The Quality of Life and Extension of Survival Time (QUEST) study compared two different treatments - pimobendan capsules vs. a benazepril hydrochloride treatment - for 260 dogs in 11 countries. The study looked at the effect both treatments had on the survival time in dogs suffering from congestive heart failure due to myxomatous mitral valve disease, according to researchers.
Results of the study are to be published in the fall edition of the Journal of Veterinary Internal Medicine.
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
